LAB Personnel Act of 2025
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
Protects the Drug Enforcement Administration's laboratory workforce from hiring freezes and workforce reductions tied to spending cuts, fund reprogramming, or probationary-status actions.
Who Benefits and How
DEA forensic laboratories and their staff gain stronger job stability and protection against generalized staffing cuts.
Who Bears the Burden and How
Department of Justice managers lose some flexibility to reduce or freeze the covered laboratory workforce outside misconduct or poor-performance cases.
Key Provisions
- Defines the DEA laboratory workforce covered by the bill.
- Exempts that workforce from hiring freezes and workforce reductions tied to certain budget or personnel actions.
- Preserves DOJ authority to act in cases of misconduct or poor performance.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Protects the Drug Enforcement Administration's laboratory workforce from hiring freezes and workforce reductions tied to spending cuts, fund reprogramming, or probationary-status actions.
Key Policy Areas
Criminal Justice, Government Operations
Primary Purpose
Protects the Drug Enforcement Administration's laboratory workforce from hiring freezes and workforce reductions tied to spending cuts, fund reprogramming, or probationary-status actions.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- DEA laboratory workforce
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Department of Justice workforce managers
Contextual inference, no direct clause citation
Sponsors
Jeanne Shaheen
D-NH | Primary Sponsor
Legislative Progress
In CommitteeMrs. Shaheen (for herself and Mr. Crapo) introduced the following …
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Drug Enforcement Administration laboratory workforce
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the attorney general"
- → Attorney General
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology